A drug that showed promise in clinical trials for Duchenne Muscular Dystrophy (DMD) decades ago is back under the microscope and has now been shown to reduce muscle wasting in mice. DMD is an incurable, fatal disease that affects mainly boys, at a rate of one in 5,000 globally. Sufferers are usually wheelchair-bound by early adolescence....